Difference between revisions of "User:Bailey.Glen"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
 
(2 intermediate revisions by the same user not shown)
Line 10: Line 10:
 
!'''Date of Last Editor Review'''
 
!'''Date of Last Editor Review'''
 
!'''Notes'''
 
!'''Notes'''
−
|-|[[BRST5:Usual_ductal_hyperplasia|Usual ductal hyperplasia]]
+
|-
 +
 
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 20: Line 22:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Columnar_cell_lesions,_including_flat_epithelial_atypia_|Columnar cell lesions, including flat epithelial atypia ]]
+
|-
 +
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 
|Disease
 
|Disease
 
|
 
|
Line 30: Line 33:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_ductal_hyperplasia|Atypical ductal hyperplasia]]
+
|-
 +
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 40: Line 44:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Sclerosing_adenosis|Sclerosing adenosis]]
+
|-
 +
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 50: Line 55:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Apocrine_adenosis_and_adenoma|Apocrine adenosis and adenoma]]
+
|-
 +
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 60: Line 66:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Microglandular_adenosis_|Microglandular adenosis ]]
+
|-
 +
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 
|Disease
 
|Disease
 
|
 
|
Line 70: Line 77:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Radial_scar_/_complex_sclerosing_lesion_|Radial scar / complex sclerosing lesion ]]
+
|-
 +
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered ]]
 
|Disease
 
|Disease
 
|
 
|
Line 80: Line 88:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Tubular_adenoma_|Tubular adenoma ]]
+
|-
 +
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 90: Line 99:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Lactating_adenoma_|Lactating adenoma ]]
+
|-
 +
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 100: Line 110:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Ductal_adenoma|Ductal adenoma]]
+
|-
 +
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 110: Line 121:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Pleomorphic_adenoma|Pleomorphic adenoma]]
+
|-
 +
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 120: Line 132:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Adenomyoepithelioma|Adenomyoepithelioma]]
+
|-
 +
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma ]]
 
|Disease
 
|Disease
 
|
 
|
Line 130: Line 143:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Malignant_adenomyoepithelioma|Malignant adenomyoepithelioma]]
+
|-
 +
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 
|Disease
 
|Disease
 
|
 
|
Line 140: Line 154:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Intraductal_papilloma|Intraductal papilloma]]
+
|-
 +
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 150: Line 165:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Papillary_ductal_carcinoma_in_situ|Papillary ductal carcinoma in situ]]
+
|-
 +
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 160: Line 176:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Encapsulated_papillary_carcinoma|Encapsulated papillary carcinoma]]
+
|-
 +
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 170: Line 187:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Solid_papillary_carcinoma_(in_situ_and_invasive)|Solid papillary carcinoma (in situ and invasive)]]
+
|-
 +
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 
|Disease
 
|Disease
 
|
 
|
Line 180: Line 198:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_papillary_carcinoma|Invasive papillary carcinoma]]
+
|-
 +
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 190: Line 209:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_lobular_hyperplasia_|Atypical lobular hyperplasia ]]
+
|-
 +
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 200: Line 220:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Lobular_carcinoma_in_situ|Lobular carcinoma in situ]]
+
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 210: Line 231:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Ductal_carcinoma_in_situ_|Ductal carcinoma in situ ]]
+
|-
 +
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 220: Line 242:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_breast_carcinoma:_General_overview|Invasive breast carcinoma: General overview]]
+
|-
 +
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 
|Disease
 
|Disease
 
|
 
|
Line 230: Line 253:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_breast_carcinoma_of_no_special_type|Invasive breast carcinoma of no special type]]
+
|-
 +
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 240: Line 264:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Microinvasive_carcinoma|Microinvasive carcinoma]]
+
|-
 +
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 250: Line 275:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_lobular_carcinoma_|Invasive lobular carcinoma ]]
+
|-
 +
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 260: Line 286:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Tubular_carcinoma|Tubular carcinoma]]
+
|-
 +
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 270: Line 297:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Cribriform_carcinoma|Cribriform carcinoma]]
+
|-
 +
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 280: Line 308:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucinous_carcinoma|Mucinous carcinoma]]
+
|-
 +
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 
|Disease
 
|Disease
 
|
 
|
Line 290: Line 319:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucinous_cystadenocarcinoma|Mucinous cystadenocarcinoma]]
+
|-
 +
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 300: Line 330:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_micropapillary_carcinoma|Invasive micropapillary carcinoma]]
+
|-
 +
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 310: Line 341:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Carcinoma_with_apocrine_differentiation|Carcinoma with apocrine differentiation]]
+
|-
 +
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 320: Line 352:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Metaplastic_carcinoma|Metaplastic carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 330: Line 363:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Acinic_cell_carcinoma|Acinic cell carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive ]]
 
|Disease
 
|Disease
 
|
 
|
Line 340: Line 374:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Adenoid_cystic_carcinoma|Adenoid cystic carcinoma]]
+
|-
 +
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 350: Line 385:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Secretory_carcinoma_|Secretory carcinoma ]]
+
|-
 +
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 360: Line 396:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Mucoepidermoid_carcinoma|Mucoepidermoid carcinoma]]
+
|-
 +
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 370: Line 407:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Polymorphous_adenocarcinoma|Polymorphous adenocarcinoma]]
+
|-
 +
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 380: Line 418:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Tall_cell_carcinoma_with_reversed_polarity|Tall cell carcinoma with reversed polarity]]
+
|-
 +
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 390: Line 429:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Neuroendocrine_tumour|Neuroendocrine tumour]]
+
|-
 +
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 
|Disease
 
|Disease
 
|
 
|
Line 400: Line 440:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Neuroendocrine_carcinoma|Neuroendocrine carcinoma]]
+
|-
 +
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 410: Line 451:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Hamartoma_|Hamartoma ]]
+
|-
 +
|[[CNS5:Subependymoma|Subependymoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 420: Line 462:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Fibroadenoma_|Fibroadenoma ]]
+
|-
 +
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 430: Line 473:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Phyllodes_tumour_|Phyllodes tumour ]]
+
|-
 +
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 
|Disease
 
|Disease
 
|
 
|
Line 440: Line 484:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Syringomatous_tumour_|Syringomatous tumour ]]
+
|-
 +
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 450: Line 495:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Nipple_adenoma_|Nipple adenoma ]]
+
|-
 +
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 460: Line 506:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Paget_disease_of_the_breast|Paget disease of the breast]]
+
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 
|Disease
 
|Disease
 
|
 
|
Line 470: Line 517:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Haemangioma|Haemangioma]]
+
|-
 +
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 480: Line 528:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Angiomatosis|Angiomatosis]]
+
|-
 +
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 
|Disease
 
|Disease
 
|
 
|
Line 490: Line 539:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Atypical_vascular_lesions_|Atypical vascular lesions ]]
+
|-
 +
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 
|Disease
 
|Disease
 
|
 
|
Line 500: Line 550:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Postradiation_angiosarcoma_of_the_breast|Postradiation angiosarcoma of the breast]]
+
|-
 +
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 510: Line 561:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Primary_angiosarcoma_of_the_breast|Primary angiosarcoma of the breast]]
+
|-
 +
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 520: Line 572:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Nodular_fasciitis|Nodular fasciitis]]
+
|-
 +
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 
|Disease
 
|Disease
 
|
 
|
Line 530: Line 583:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Myofibroblastoma|Myofibroblastoma]]
+
|-
 +
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 
|Disease
 
|Disease
 
|
 
|
Line 540: Line 594:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Desmoid_fibromatosis_|Desmoid fibromatosis ]]
+
|-
 +
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 
|Disease
 
|Disease
 
|
 
|
Line 550: Line 605:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Inflammatory_myofibroblastic_tumour_|Inflammatory myofibroblastic tumour ]]
+
|-
 +
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 
|Disease
 
|Disease
 
|
 
|
Line 560: Line 616:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Schwannoma_|Schwannoma ]]
+
|-
 +
|[[CNS5:Pineocytoma|Pineocytoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 570: Line 627:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Neurofibroma_|Neurofibroma ]]
+
|-
 +
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 
|Disease
 
|Disease
 
|
 
|
Line 580: Line 638:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Granular_cell_tumour|Granular cell tumour]]
+
|-
 +
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 590: Line 649:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Leiomyoma|Leiomyoma]]
+
|-
 +
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 
|Disease
 
|Disease
 
|
 
|
Line 600: Line 660:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Leiomyosarcoma_|Leiomyosarcoma ]]
+
|-
 +
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 610: Line 671:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Lipoma_|Lipoma ]]
+
|-
 +
|[[CNS5:Schwannoma|Schwannoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 620: Line 682:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Angiolipoma_|Angiolipoma ]]
+
|-
 +
|[[CNS5:Neurofibroma|Neurofibroma]]
 
|Disease
 
|Disease
 
|
 
|
Line 630: Line 693:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Liposarcoma_|Liposarcoma ]]
+
|-
 +
|[[CNS5:Perineurioma|Perineurioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 640: Line 704:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Pseudoangiomatous_stromal_hyperplasia|Pseudoangiomatous stromal hyperplasia]]
+
|-
 +
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 
|Disease
 
|Disease
 
|
 
|
Line 650: Line 715:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Extranodal_marginal_zone_lymphoma_of_mucosa-associated_lymphoid_tissue_(MALT_lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]
+
|-
 +
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 660: Line 726:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Follicular_lymphoma_|Follicular lymphoma ]]
+
|-
 +
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 670: Line 737:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Diffuse_large_B-cell_lymphoma_|Diffuse large B-cell lymphoma ]]
+
|-
 +
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 
|Disease
 
|Disease
 
|
 
|
Line 680: Line 748:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Burkitt_lymphoma|Burkitt lymphoma]]
+
|-
 +
|[[CNS5:Meningioma|Meningioma]]
 
|Disease
 
|Disease
 
|
 
|
Line 690: Line 759:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Breast_implant-associated_anaplastic_large_cell_lymphoma_|Breast implant-associated anaplastic large cell lymphoma ]]
+
|-
 +
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 
|Disease
 
|Disease
 
|
 
|
Line 700: Line 770:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Gynaecomastia|Gynaecomastia]]
+
|-
 +
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 
|Disease
 
|Disease
 
|
 
|
Line 710: Line 781:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Carcinoma_in_situ|Carcinoma in situ]]
+
|-
 +
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 720: Line 792:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Invasive_carcinoma|Invasive carcinoma]]
+
|-
 +
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 730: Line 803:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Metastases_to_the_breast|Metastases to the breast]]
+
|-
 +
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 
|Disease
 
|Disease
 
|
 
|
Line 740: Line 814:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]]
+
|-
 +
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 750: Line 825:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Cowden_syndrome|Cowden syndrome]]
+
|-
 +
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 
|Disease
 
|Disease
 
|
 
|
Line 760: Line 836:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Ataxia-telangiectasia|Ataxia-telangiectasia]]
+
|-
 +
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 770: Line 847:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Li-Fraumeni_syndrome,_TP53-associated|Li-Fraumeni syndrome, TP53-associated]]
+
|-
 +
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 780: Line 858:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Li-Fraumeni_syndrome,_CHEK2-associated|Li-Fraumeni syndrome, CHEK2-associated]]
+
|-
 +
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 790: Line 869:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:CDH1-associated_breast_cancer|CDH1-associated breast cancer]]
+
|-
 +
|[[CNS5:Chordoma|Chordoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 800: Line 880:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:PALB2-associated_cancers|PALB2-associated cancers]]
+
|-
 +
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 
|Disease
 
|Disease
 
|
 
|
Line 810: Line 891:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
+
|-
 +
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 820: Line 902:
 
|
 
|
 
|
 
|
−
|-|[[BRST5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
+
|-
 +
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 
|Disease
 
|Disease
 
|
 
|

Latest revision as of 12:28, 26 January 2024

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Astrocytoma, IDH-mutant Disease
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease
Glioblastoma, IDH-wildtype Disease
Diffuse astrocytoma, MYB- or MYBL1-altered Disease
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease
Diffuse midline glioma, H3 K27-altered Disease
Diffuse hemispheric glioma, H3 G34-mutant Disease
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
Medulloblastoma, WNT-activated Disease
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
Meningioma Disease
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
Germ cell tumours of the CNS Disease
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
Neurofibromatosis type 1 Disease
Neurofibromatosis type 2 Disease
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease
Cowden syndrome Disease
Constitutional mismatch repair deficiency syndrome Disease
Familial adenomatous polyposis 1 Disease
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://content.ccga.io/index.php?title=User:Bailey.Glen&oldid=14124"